Neuroblastoma conference comes Down Under for the first time
The Advances in Neuroblastoma Research (ANR) Congress is coming to the Cairns Convention Centre next month, marking the first time the biennial conference has been held in the Southern Hemisphere.
The meeting will provide a key opportunity for research scientists, clinicians, early-career fellows, nurses and other allied healthcare workers to be updated on the latest basic, translational and clinical research developments in the field of childhood neuroblastoma, with workshops to be held under the following themes:
- Novel clinical trial design (focus on personalised medicine).
- Epigenetic regulation and genome editing in cancer.
- Next Generation Risk Stratification: New approaches to identify highest risk patients (or ultrahigh-risk patients).
- Emerging technologies for exploration of tumour heterogeneity, clonal evolution and progression in neuroblastoma.
In addition to the main scientific meeting, being held from 19–23 June, there will be a full-day symposium for parents on 24 June. Featuring keynote speaker Donna Ludwinski, Research Programs and Partnership, Solving Kids’ Cancer, these sessions will be open to nursing delegates.
The meeting will provide opportunities for delegates to explore and take advantage of the beautiful surroundings, with Cairns located on the doorstep of both the Great Barrier Reef and ancient tropical rainforests. Participants will also have the chance to experience culinary treats and Aboriginal traditions, dance and folklore.
To register for the conference and/or Neuroblastoma Parents Day, visit http://www.anr2016.org.
Research project to produce fish-free omega-3
SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...
Biodegradable smart patch can detect and treat blood clots
Researchers have developed a biodegradable smart patch that detects pressure changes and releases...
Biotech manufacturing facility opens in Brisbane
ENTRI, a purpose-built multimodal facility which will enable biotech companies to manufacture...
